Research Papers:
Focal adhesion molecule Kindlin1 mediates activation of TGFβ signaling by interacting with TGFβRI SARA and Smad3 in colorectal cancer cells
PDF | Full Text | How to cite
Metrics: PDF 3006 views | Full Text 3058 views
Jinfeng Kong1,2,*, Juan Du1,*, Yunling Wang1, Mingzi Yang1, Jianchao Gao1, Xiaofan Wei1, Weigang Fang1,2, Jun Zhan1, Hongquan Zhang1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), State Key Laboratory of Natural and Biomimetic Drugs, Department of Anatomy, Histology and Embryology, Peking University Health Science Center, Beijing 100191, China
2Department Pathology, Peking University Health Science Center, Beijing 100191, China
*These authors have contributed equally to this work
Correspondence to:
Hongquan Zhang, email: [email protected]
Weigang Fang, email: [email protected]
Jun Zhan, email: [email protected]
Keywords: Kindlin-1, colorectal carcinoma, TGF-β receptor I, Smad3, Smad anchor for receptor activation (SARA)
Received: August 17, 2016 Accepted: October 05, 2016 Published: October 20, 2016
ABSTRACT
Kindlin-1, an integrin-interacting protein, has been implicated in TGF-β/Smad3 signaling. However, the molecular mechanism underlying Kindlin-1 regulation of TGF-β/Smad3 signaling remains elusive. Here, we reported that Kindlin-1 is an important mediator of TGF-β/Smad3 signaling by showing that Kindlin-1 physically interacts with TGF-β receptor I (TβRI), Smad anchor for receptor activation (SARA) and Smad3. Kindlin-1 is required for the interaction of Smad3 with TβRI, Smad3 phosphorylation, nuclear translocation, and finally the activation of TGF-β/Smad3 signaling pathway. Functionally, Kindlin-1 promoted colorectal cancer (CRC) cell proliferation in vitro and tumor growth in vivo, and was also required for CRC cell migration and invasion via an epithelial to mesenchymal transition. Kindlin-1 was found to be increased with the CRC progression from stages I to IV. Importantly, raised expression level of Kindlin-1 correlates with poor outcome in CRC patients. Taken together, we demonstrated that Kindlin-1 promotes CRC progression by recruiting SARA and Smad3 to TβRI and thereby activates TGF-β/Smad3 signaling. Thus, Kindlin-1 is a novel regulator of TGF-β/Smad3 signaling and may also be a potential target for CRC therapeutics.